McLean, VA // Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be held in the Regency D ballroom of the Hyatt Regency McCormick Place, directly adjacent to the McCormick Place.
McLean, VA // Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual cancers.
Washington, DC // ZERO is launching the Decode Your Prostate Cancer program in partnership with Perthera, the leading Therapeutics Intelligence Company™, to give men battling advanced prostate cancer the ability to create individualized treatment plans. Every patient’s prostate cancer is as unique as his genes. As we continue to fight this terrible disease, personalized medicine is more important than ever.
McLean, VA –(PR.com)– Perthera Inc.’s, Subha Madhavan, PhD, Chief Bioinformatics Officer, will be speaking at the 11th Annual Fall Conference of Health 2.0 on Healthcare Innovations, Oct 1 – 4 in Santa Clara, CA, in the Personalized Health Track “Turning Data into Value.”